Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) General Information
Description
UniverCyte technology patent located in Silicon Valley, California. The UniverCyte technology uses the tolerogenic molecule HLA-G, modified to be stably expressed on the cell-extracellular membrane, to confer low immune observability to the resulting cells.
Contact Information
Corporate Office
- CA
- United States
Corporate Office
- CA
- United States
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) FAQs
-
Where is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) headquartered?
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) is headquartered in CA.
-
What industry is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) in?
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)’s primary industry is Buildings and Property.
-
Is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) a private or public company?
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) is a Private company.
-
What is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)’s current revenue?
The current revenue for Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) is .
-
Who are Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)’s investors?
Escape Therapeutics has invested in Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California).
-
When was Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) acquired?
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) was acquired on 16-Aug-2019.
-
Who acquired Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)?
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) was acquired by AgeX Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process